3
Announcements
Trials
Browse
Landscape
Status
Completed
74
Recruiting
48
Terminated
35
Active not recruiting
25
Unknown
8
Withdrawn
6
Not yet recruiting
3
Enrolling by invitation
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
5
Thoracic
2
Gastrointestinal
2
Other solid neoplasm
1
Gynecologic
1
Genitourinary
1
CNS
1
Breast
1
Conditions
Prostatic Neoplasms
37
Urinary Bladder Neoplasms
12
Breast Neoplasms
7
Neoplasms
6
Kidney Neoplasms
5
Carcinoma, Renal Cell
5
Adenocarcinoma
5
Carcinoma, Transitional Cell
4
Stomach Neoplasms
3
Ovarian Neoplasms
3
Lung Neoplasms
3
Heart Failure
3
Disease
3
Colorectal Neoplasms
3
Anxiety Disorders
3
Triple Negative Breast Neoplasms
2
Pulmonary Disease, Chronic Obstructive
2
Pancreatic Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Kidney Failure, Chronic
2
Kidney Diseases
2
Hematologic Neoplasms
2
Cardiovascular Diseases
2
Carcinoma, Non-Small-Cell Lung
2
Brain Neoplasms
2
Asthma
2
von Hippel-Lindau Disease
1
the Detection of Prostate Cancer in Men
1
Uterine Cervical Neoplasms
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Squamous Cell Carcinoma of Head and Neck
×
Genitourinary
×
Clear all
NCT06885424
2026-05-20
DESCENT-1
A2 Biotherapeutics Inc.
Enrolling by invitation
400 enrolled